223 related articles for article (PubMed ID: 18263602)
1. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Goodman P; Penson DF; Thompson IM
Am J Epidemiol; 2008 Apr; 167(8):925-34. PubMed ID: 18263602
[TBL] [Abstract][Full Text] [Related]
2. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
[TBL] [Abstract][Full Text] [Related]
3. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Schenk JM; Calip GS; Tangen CM; Goodman P; Parsons JK; Thompson IM; Kristal AR
Am J Epidemiol; 2012 Jul; 176(2):156-63. PubMed ID: 22759721
[TBL] [Abstract][Full Text] [Related]
4. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
[TBL] [Abstract][Full Text] [Related]
5. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.
Schenk JM; Kristal AR; Arnold KB; Tangen CM; Neuhouser ML; Lin DW; White E; Thompson IM
Am J Epidemiol; 2011 Jun; 173(12):1419-28. PubMed ID: 21540324
[TBL] [Abstract][Full Text] [Related]
6. Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
Schenk JM; Kristal AR; Neuhouser ML; Tangen CM; White E; Lin DW; Thompson IM
Prostate; 2009 Sep; 69(12):1303-11. PubMed ID: 19475640
[TBL] [Abstract][Full Text] [Related]
7. Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
Unger JM; Till C; Thompson IM; Tangen CM; Goodman PJ; Wright JD; Barlow WE; Ramsey SD; Minasian LM; Hershman DL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27565902
[TBL] [Abstract][Full Text] [Related]
8. Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men.
Rohrmann S; Giovannucci E; Willett WC; Platz EA
Am J Clin Nutr; 2007 Feb; 85(2):523-9. PubMed ID: 17284753
[TBL] [Abstract][Full Text] [Related]
9. Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.
Neuhouser ML; Kristal AR; Patterson RE; Goodman PJ; Thompson IM
Nutr Cancer; 2001; 39(1):12-8. PubMed ID: 11588893
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Schenk JM; Kristal AR; Neuhouser ML; Tangen CM; White E; Lin DW; Kratz M; Thompson IM
Am J Epidemiol; 2010 Mar; 171(5):571-82. PubMed ID: 20142396
[TBL] [Abstract][Full Text] [Related]
11. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
[TBL] [Abstract][Full Text] [Related]
12. Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia.
Ambrosini GL; de Klerk NH; Mackerras D; Leavy J; Fritschi L
BJU Int; 2008 Apr; 101(7):853-60. PubMed ID: 18070188
[TBL] [Abstract][Full Text] [Related]
13. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies.
Lee JE; Spiegelman D; Hunter DJ; Albanes D; Bernstein L; van den Brandt PA; Buring JE; Cho E; English DR; Freudenheim JL; Giles GG; Graham S; Horn-Ross PL; Håkansson N; Leitzmann MF; Männistö S; McCullough ML; Miller AB; Parker AS; Rohan TE; Schatzkin A; Schouten LJ; Sweeney C; Willett WC; Wolk A; Zhang SM; Smith-Warner SA
J Natl Cancer Inst; 2008 Dec; 100(23):1695-706. PubMed ID: 19033572
[TBL] [Abstract][Full Text] [Related]
14. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.
Neuhouser ML; Schenk J; Song YJ; Tangen CM; Goodman PJ; Pollak M; Penson DF; Thompson IM; Kristal AR
Prostate; 2008 Sep; 68(13):1477-86. PubMed ID: 18618736
[TBL] [Abstract][Full Text] [Related]
16. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
[TBL] [Abstract][Full Text] [Related]
17. Association between dietary phytochemical index and risk of benign prostatic hyperplasia: a case-control study.
Mousavi SN; Nouri M; Yousefi Rad E; Kazemi R; Birjandi M; Coe S; Saboori S
J Health Popul Nutr; 2024 Mar; 43(1):35. PubMed ID: 38429831
[TBL] [Abstract][Full Text] [Related]
18. Physical activity and benign prostatic hyperplasia.
Platz EA; Kawachi I; Rimm EB; Colditz GA; Stampfer MJ; Willett WC; Giovannucci E
Arch Intern Med; 1998 Nov; 158(21):2349-56. PubMed ID: 9827786
[TBL] [Abstract][Full Text] [Related]
19. Benign prostate hyperplasia and nutrition.
Das K; Buchholz N
Clin Nutr ESPEN; 2019 Oct; 33():5-11. PubMed ID: 31451276
[TBL] [Abstract][Full Text] [Related]
20. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
